Table 1.

Demographics of patients with bladder pain syndrome (N=62).

	Lower Pain Catastrophizing score (PCS≤30) N = 47	Higher Pain Catastrophizing score (PCS>30) N = 15	P-value
Age (years)	44.7 (+/−2.2)	42.1 (+/−3.7)	0.57a
Race (N, %)
Caucasian	41 (87.2)	14 (93.3)	0.68b
African American	4 (8.5)	1 (6.7)
Other	2 (4.3)	0 (0.0)
BMI (kg/m2)	25.0 (+/−5.2)	22.6 (+/−3.5)	0.10a
Parity (median, range)	0 (0–5)	0 (0–2)	0.93c
Postmenopausal (N, %)	19 (40.4)	6 (40.0)	0.99b
Current Treatment(s) (N, %)
SSRIs/SNRIs	14 (30.0)	4 (26.7)	0.55d
Tricyclic Anti-depressants	10 (21.2)	3 (20.0)	0.62d
Anxiolytics	13 (27.7)	8 (53.3)	0.07b
Antipsychotics	2 (4.3)	0 (0.0)	0.57d
Lamotrigine	2 (4.3)	0 (0.0)	0.57d
Gabapentin	4 (8.5)	2 (13.3)	0.24d
Antihistamines	14 (29.8)	5 (33.3)	0.79b
Anticholinergics	2 (4.3)	0 (0.0)	0.53d
Analgesics	20 (42.6)	6 (40.0)	0.86b
Pentosan polysulfate	7 (14.9)	3 (20.0)	0.46d
Bladder Instillations	3 (6.4)	4 (46.7)	0.05d
Botox	1 (2.1)	0 (0.0)	0.76d
Interstim	0 (0.0)	0 (0.0)
Past Surgical History (N, %)
Hysterectomy	11 (23.4)	0 (0.0)	0.03 d
Prolapse	1 (2.1)	0 (0.0)	0.76d
Incontinence Procedure	1 (2.1)	1 (6.7)	0.43d
Oophorectomy	6 (12.8)	0 (0.0)	0.18d
Appendectomy	10 (21.3)	1 (6.7)	0.19d
Past Medical History (N, %)
Depression	11 (23.4)	5 (33.3)	0.34b
Anxiety	14 (29.8)	6 (40.0)	0.46b
Vulvodynia	2 (4.3)	4 (26.7)	0.03 d
Pelvic Floor Dysfunction	3 (6.4)	4 (26.7)	0.05d
Fibromyalgia	3 (6.4)	4 (26.7)	0.05d
Chronic Fatigue Syndrome	4 (8.5)	1 (6.7)	0.65d
Migraine	8 (17.0)	6 (40.0)	0.06b
Irritable Bowel Syndrome	12 (25.5)	6 (40.0)	0.28b
Diabetes	3 (6.4)	0 (0.0)	0.43d
Hypertension	4 (8.5)	1 (6.7)	0.65d

^aIndependent t-test

^bChi² test

^cEquality of medians

^dFisher exact test

Statistical significance for all tests, p<0.05

PCS=pain catastrophizing scale

SSRIs/SNRIs=selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitors